Morrisons bid highlights the tricky business of stakeholder M&A
There is little more dangerous in the world of mergers and acquisitions than a politician with a microphone. Pfizer’s interest in AstraZeneca wasn’t even official in 2014 before the then-shadow business secretary Chuka Umunna grabbed one to warn about “asset stripping” and how any deal would be a bad one for “British industry.” Pfizer’s subsequent bid, … Read more